126 related articles for article (PubMed ID: 26958987)
1. Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.
Trabbic KR; Bourgault JP; Shi M; Clark M; Andreana PR
Org Biomol Chem; 2016 Apr; 14(13):3350-5. PubMed ID: 26958987
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
3. Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing.
Trabbic KR; Kleski KA; Shi M; Bourgault JP; Prendergast JM; Dransfield DT; Andreana PR
Cancer Immunol Immunother; 2018 Sep; 67(9):1437-1447. PubMed ID: 30030557
[TBL] [Abstract][Full Text] [Related]
4. Sialyl-Tn Polysaccharide A1 as an Entirely Carbohydrate Immunogen: Synthesis and Immunological Evaluation.
Shi M; Kleski KA; Trabbic KR; Bourgault JP; Andreana PR
J Am Chem Soc; 2016 Nov; 138(43):14264-14272. PubMed ID: 27726393
[TBL] [Abstract][Full Text] [Related]
5. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Ulsemer P; Henderson G; Toutounian K; Löffler A; Schmidt J; Karsten U; Blaut M; Goletz S
Cancer Immunol Immunother; 2013 May; 62(5):875-87. PubMed ID: 23381581
[TBL] [Abstract][Full Text] [Related]
6. The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17.
De Silva RA; Appulage DK; Pietraszkiewicz H; Bobbitt KR; Media J; Shaw J; Valeriote FA; Andreana PR
Cancer Immunol Immunother; 2012 Apr; 61(4):581-5. PubMed ID: 22297566
[TBL] [Abstract][Full Text] [Related]
7. Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage.
Irazoqui FJ; Lopez PH; Vides MA; Nores GA
Glycobiology; 2000 Aug; 10(8):781-7. PubMed ID: 10929004
[TBL] [Abstract][Full Text] [Related]
8. Immune response to Thomsen-Friedenreich disaccharide and glycan engineering.
Irazoqui FJ; Sendra VG; Lardone RD; Nores GA
Immunol Cell Biol; 2005 Aug; 83(4):405-12. PubMed ID: 16033536
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
Butschak G; Karsten U
Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291
[TBL] [Abstract][Full Text] [Related]
10. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
11. Computational screening of the human TF-glycome provides a structural definition for the specificity of anti-tumor antibody JAA-F11.
Tessier MB; Grant OC; Heimburg-Molinaro J; Smith D; Jadey S; Gulick AM; Glushka J; Deutscher SL; Rittenhouse-Olson K; Woods RJ
PLoS One; 2013; 8(1):e54874. PubMed ID: 23365681
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
13. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
[TBL] [Abstract][Full Text] [Related]
14. Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen.
Chaturvedi R; Heimburg J; Yan J; Koury S; Sajjad M; Abdel-Nabi HH; Rittenhouse-Olson K
Appl Radiat Isot; 2008 Mar; 66(3):278-87. PubMed ID: 17890096
[TBL] [Abstract][Full Text] [Related]
15. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
16. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
[TBL] [Abstract][Full Text] [Related]
18. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation.
Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D
Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404
[No Abstract] [Full Text] [Related]
19. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
20. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
